{
 "name": "彥臣",
 "slug": "tw-4732",
 "aliases": [
  "彥臣生技藥品股份有限公司",
  "NBM",
  "4732"
 ],
 "ticker": "4732",
 "industry": "生技醫療業",
 "website": "https://www.naturewiseppls.com/",
 "summary": "彥臣（4732）是興櫃的生技醫療類股公司，2000 年成立，2007 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "彥臣生技藥品股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "NBM",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2007-12-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2000-12-29",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "黃中洋",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "董事長暫代",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 496435000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.naturewiseppls.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "主要產品：壽美降脂一號",
   "value": "年報載為藥品；降低高膽固醇血症與高三酸甘油酯血症",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：脂祐全",
   "value": "紅麴保健食品；採製藥等級紅麴菌種",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：清祐全",
   "value": "紅麴、納豆及輔酶Q10等成分的複方保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs新慧祐全",
   "value": "含PPLs台灣綠蜂膠成分的保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs糖祐全",
   "value": "植物複方保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs康祐全",
   "value": "含金銀花萃取物等原料的植物複方保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs視祐全",
   "value": "含PPLs、葉黃素、玉米黃素、花青素等成分的保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs健祐全滴劑",
   "value": "主要成分為PPLs台灣綠蜂膠萃取液的健康食品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "主要產品：PPLs健祐全噴劑",
   "value": "主要成分為PPLs台灣綠蜂膠萃取液的保健產品",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "公司年報第42至43頁；描述限原文產品與用途，未據此推定醫材許可。"
  },
  {
   "claim": "管線：NBM-BMX（HDAC8抑制劑）",
   "value": "實體腫瘤或新診斷膠質母細胞瘤｜臨床一/二期；招募中｜台灣",
   "unit": "",
   "as_of": "2026-04-29",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06012695",
   "note": "NCT06012695；as_of為試驗Last Update Posted。"
  },
  {
   "claim": "管線：NBM-BMX（併用temozolomide延伸試驗）",
   "value": "新診斷膠質母細胞瘤｜臨床一/二期；招募中｜台灣",
   "unit": "",
   "as_of": "2026-05-06",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07569042",
   "note": "NCT07569042；as_of為試驗Last Update Posted。"
  },
  {
   "claim": "管線：NBM-BMX（轉移性葡萄膜黑色素瘤）",
   "value": "轉移性葡萄膜黑色素瘤｜臨床一/二期；招募中｜美國",
   "unit": "",
   "as_of": "2025-11-28",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07136181",
   "note": "NCT07136181；as_of為試驗Last Update Posted。"
  },
  {
   "claim": "管線：HDAC11抑制劑（未揭露代號）",
   "value": "適應症未揭露｜化合物庫生物活性及機轉研究｜地區未揭露",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "114年度年報紙本第42頁；公司未公開臨床期別或適應症，保留未揭露，不推定IND。"
  },
  {
   "claim": "管線：NW-Si-2502（候選藥物）",
   "value": "適應症未揭露｜生產流程優化與品質分析方法建立｜地區未揭露",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://www.naturewiseppls.com/download/114%E5%B9%B4%E5%A0%B1/?wpdmdl=7158",
   "note": "114年度年報紙本第42頁，核酸自動生產封裝技術項目。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4732.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}